Some lawmakers say no to drug advertising

Share this article:
Several lawmakers in Congress are calling on pharmaceutical companies to stop or at least tamp down their direct-to-consumer advertisements. The $4.3 billion ad sector is being cited as a contributor to high healthcare costs. Rep. James Moran (D-VA) said the ads violate decency standards. Rep. Henry Waxman (D-CA) said ads should not be shown right after receiving marketing approval from the government. Others say pharmaceutical companies should not be allowed to deduct advertising costs as a business expense. DTC was the second-biggest ad spender last year, according to Nielsen.
Share this article:

More in Products

LeadingAge's CAST releases medication management tools

LeadingAge's Center for Aging Services Technologies release new tools last week to help long-term care providers identify the best medication management product.

Butler Mobility updates paint colors for platform lifts

Butler Mobility updates paint colors for platform lifts

Butler Mobility has widened the spectrum of paint color choices for its Incline Platform Lifts line.

NeuroMetrix releases pain management system

NeuroMetrix releases pain management system

NeuroMetrix Inc. has created the SENSUS™ Pain Management System, a wearable neurostimulation technology developed for chronic neuropathic pain, including painful diabetic neuropathy.